DANCR and hepatocellular carcinoma: Interestingly, even though lncRNA DANCR originally was identified as an oncogene in hepatocellular carcinoma, Sha S. and colleagues revealed that DANCR results in being upregulated also in TNBC, where it could represent a promising target for TNBC treatment [40,41].